- As part of an effort to analyze a potential acquisition by an investment group of a large pesticide manufacturing business, Candida evaluated the research, development, and regulatory status of several of the
key products.
- On behalf of a U.S. chemical company acquiring another chemical company, undertook an inspection and an analysis of several plant sites in the U.S. and Germany to determine the extent of compliance with FDA's
current Good Manufacturing Practices with respect to food additives, cosmetics, and bulk pharmaceuticals and pharmaceutical intermediates.
- A large European company was considering establishing a business based on its fermentation process development and scale-up capabilities. An evaluation was made of the business potential and competitive
positions, and advice was provided concerning the directions the business should pursue.
- Evaluated possible production of a natural biochemical through the application of recombinant DNA technology to plants, yeasts, or bacteria; carried out preliminary planning of the R & D program; and
estimated R & D costs and potential production costs at various capacities and through various routes.
|
